FDA Study Population Requirement for BE Studies: Ethics or Science [Regulatives / Guidelines]

posted by bebac_fan – US, 2018-05-15 20:57 (897 d 18:50 ago) – Posting: # 18767
Views: 1,743

Hi Obinoscopy,

Thanks for bringing this up for discussion. We can all think of many examples where PK in intended populations may be different than the general. However, it is hard to think of situations where a physiological state will selectively alter the PK of a test drug.

After thinking for a bit, and quite a bit of stretching, I could come up with gastric pH (e.g. increased in elderly) maybe affecting BA for a pH liable dispersion matrix. Perhaps other formulation dependent things for reduced GI motility. But I think this is in general a "feel good" clause and not scientifically rooted.


Complete thread:

 Admin contact
21,179 posts in 4,414 threads, 1,477 registered users;
online 9 (0 registered, 9 guests [including 4 identified bots]).
Forum time: Thursday 14:47 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz